[go: up one dir, main page]

SMT201400061B - Procedimento di preparazione di esteri attivati - Google Patents

Procedimento di preparazione di esteri attivati

Info

Publication number
SMT201400061B
SMT201400061B SM201400061T SM201400061T SMT201400061B SM T201400061 B SMT201400061 B SM T201400061B SM 201400061 T SM201400061 T SM 201400061T SM 201400061 T SM201400061 T SM 201400061T SM T201400061 B SMT201400061 B SM T201400061B
Authority
SM
San Marino
Prior art keywords
preparation process
activated esters
esters
activated
preparation
Prior art date
Application number
SM201400061T
Other languages
English (en)
Italian (it)
Inventor
Antony Bigot
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SMT201400061B publication Critical patent/SMT201400061B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • C07D213/71Sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM201400061T 2008-12-17 2014-05-26 Procedimento di preparazione di esteri attivati SMT201400061B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0807090A FR2939795B1 (fr) 2008-12-17 2008-12-17 Procede de preparation d'esters actives
PCT/FR2009/052528 WO2010076474A1 (fr) 2008-12-17 2009-12-15 Procede de preparation d'esters actives

Publications (1)

Publication Number Publication Date
SMT201400061B true SMT201400061B (it) 2014-07-07

Family

ID=40614691

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400061T SMT201400061B (it) 2008-12-17 2014-05-26 Procedimento di preparazione di esteri attivati

Country Status (25)

Country Link
US (1) US8314244B2 (ja)
EP (1) EP2379501B1 (ja)
JP (1) JP5467111B2 (ja)
KR (1) KR101645051B1 (ja)
CN (1) CN102292318B (ja)
AU (1) AU2009334689B2 (ja)
BR (1) BRPI0922972B1 (ja)
CA (1) CA2747105C (ja)
CY (1) CY1115035T1 (ja)
DK (1) DK2379501T3 (ja)
ES (1) ES2459918T3 (ja)
FR (1) FR2939795B1 (ja)
HR (1) HRP20140368T1 (ja)
IL (1) IL213525A (ja)
ME (1) ME01827B (ja)
MX (1) MX2011006624A (ja)
MY (1) MY156761A (ja)
PL (1) PL2379501T4 (ja)
PT (1) PT2379501E (ja)
RS (1) RS53267B (ja)
RU (1) RU2506258C2 (ja)
SG (1) SG172179A1 (ja)
SI (1) SI2379501T1 (ja)
SM (1) SMT201400061B (ja)
WO (1) WO2010076474A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963007B1 (fr) 2010-07-26 2013-04-05 Sanofi Aventis Derives anticancereux, leur preparation et leur application therapeutique
US11352325B2 (en) 2011-09-28 2022-06-07 Waters Technologies Corporation Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals
US10436790B2 (en) 2011-09-28 2019-10-08 Waters Technologies Corporation Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals
JP6774748B2 (ja) * 2014-08-13 2020-10-28 ウオーターズ・テクノロジーズ・コーポレイシヨン 強められたms信号を有するグリカンおよび他の生体分子の迅速蛍光タグ付け
DK3748340T3 (da) 2014-10-30 2022-04-19 Waters Technologies Corp Fremgangsmåder til hurtig præparering af mærkede glykosylaminer og til analyse af glykosylerede biomolekyler, som fremstiller samme
EP3218352B1 (en) 2014-11-13 2020-08-05 Waters Technologies Corporation Method for liquid chromatography calibration for labeled n-glycans, method for preparing a dextran ladder calibrant and calibrant
EP3472132A4 (en) 2016-06-21 2020-01-15 Waters Technologies Corporation FLUORESCENCE LABELING OF GLYCANS AND OTHER BIOMOLECULES BY REDUCING AMINATION FOR IMPROVED MASS SPECTROMETRY SIGNALS
EP3472621A4 (en) 2016-06-21 2020-03-04 Waters Technologies Corporation Methods of electrospray ionization of glycans modified with amphipathic, strongly basic moieties
EP3479103B1 (en) 2016-07-01 2022-04-20 Waters Technologies Corporation Methods for the rapid preparation of labeled glycosylamines from complex matrices using molecular weight cut off filtration and on-filter deglycosylation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5710101B2 (ja) * 1972-10-24 1982-02-24
US5872261A (en) 1997-09-18 1999-02-16 Pierce Chemical Company Preparation of sulfo-N- hydroxy succinimide salts with intermediate formation of diester
US5892057A (en) 1997-09-18 1999-04-06 Pierce Chemical Company Preparation of sulfo-N-hydroxysuccinimide salts
JP2002316987A (ja) * 2001-04-20 2002-10-31 Sankyo Co Ltd 2−アルコキシベンゼン誘導体を含有する医薬
JP2006500364A (ja) * 2002-08-16 2006-01-05 イムノージェン インコーポレーテッド 高い反応性と溶解度を有する架橋剤および小分子薬物の標的化送達用コンジュゲートの調製におけるそれらの使用
JP4929461B2 (ja) * 2004-10-29 2012-05-09 国立大学法人富山大学 高蛍光量子収率型疎水性蛍光プローブ、それを用いる生体高分子検出法ならびに生体高分子間相互作用検出法
WO2006051047A1 (en) * 2004-11-09 2006-05-18 Ciba Specialty Chemicals Holding Inc. N-substituted imides as polymerization initiators
US8871720B2 (en) * 2005-07-07 2014-10-28 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus

Also Published As

Publication number Publication date
JP5467111B2 (ja) 2014-04-09
RS53267B (sr) 2014-08-29
EP2379501A1 (fr) 2011-10-26
HK1163664A1 (zh) 2012-09-14
KR101645051B1 (ko) 2016-08-02
AU2009334689B2 (en) 2015-10-08
US8314244B2 (en) 2012-11-20
PL2379501T3 (pl) 2014-07-31
CA2747105C (fr) 2017-02-28
BRPI0922972A2 (pt) 2015-08-11
PL2379501T4 (pl) 2014-12-31
BRPI0922972B1 (pt) 2021-06-01
EP2379501B1 (fr) 2014-01-22
MX2011006624A (es) 2011-11-04
KR20110094311A (ko) 2011-08-23
WO2010076474A1 (fr) 2010-07-08
RU2506258C2 (ru) 2014-02-10
RU2011129652A (ru) 2013-01-27
HRP20140368T1 (hr) 2014-06-20
SG172179A1 (en) 2011-07-28
SI2379501T1 (sl) 2014-05-30
AU2009334689A1 (en) 2011-07-07
CN102292318A (zh) 2011-12-21
JP2012512234A (ja) 2012-05-31
FR2939795B1 (fr) 2010-12-17
US20110313168A1 (en) 2011-12-22
ME01827B (me) 2014-12-20
DK2379501T3 (da) 2014-04-28
FR2939795A1 (fr) 2010-06-18
CA2747105A1 (fr) 2010-07-08
MY156761A (en) 2016-03-31
IL213525A (en) 2014-11-30
BRPI0922972A8 (pt) 2018-02-06
CY1115035T1 (el) 2016-12-14
PT2379501E (pt) 2014-05-02
CN102292318B (zh) 2014-01-01
IL213525A0 (en) 2011-07-31
ES2459918T3 (es) 2014-05-12

Similar Documents

Publication Publication Date Title
SMT201400061B (it) Procedimento di preparazione di esteri attivati
PL2352497T3 (pl) Proces przygotowania estrów aminokwasowych delta-9-thc
SMT201600254B (it) Procedimento per la preparazione di idromagnesite
LT2596786T (lt) Eikozapentaeno rūgšties etilo esterio naudojimas hipertriglicidemijai gydyti
EP2442645A4 (en) choline
PL3056224T3 (pl) Sposób sterylizacji
EP2490701A4 (en) Cardiomyocyte production
EP2437790A4 (en) conjugation
EP2289050A4 (en) SHADER INTERFACES
EP2408473A4 (en) seeding method
BR112012005146A2 (pt) fotobiorreator
EP2444389A4 (en) PROCESS FOR THE PREPARATION OF 2-FLUOROACRYLIC ESTERS
IT1393061B1 (it) Procedimento integrato per la produzione di bio-olio da microrganismi
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
SMT201500268B (it) Derivato di 5-idrossipirimidin-4-carbossammide
ZA201006971B (en) Methods and compositions for production of acetaldehyde
EP2234716A4 (en) CATALYSTS FOR ESTERING EPOXYED SUBSTANCES AND METHOD FOR THEIR USE
FI20085693A0 (fi) Biosignaalin prosessointi
BRPI1009018A2 (pt) fotobiorreator
ZA201101645B (en) Process for prodcution of vaccines
IT1397503B1 (it) Processo per la preparazione di olopatadina
BRPI0906184A2 (pt) método de preparação de micropartículas biodegradáveis contendo medicamentos
EP2461319A4 (en) RIGHT PIANO ACTION
EP2358693A4 (en) PREPARATION OF DOCETAXEL
PL389421A1 (pl) Sposób otrzymywania estrów chityny